Amigrawest 2.5 mg 4 tablets

Tradename

Amigrawest

Amigrawest

Composition

Each p/ o tablet contains:

Zolmitriptan — 2.5mg

Properties

Zolmitriptan causes vasoconstriction in intracranial blood vessels (including arteriovenous anastomoses) and sensory endings of the trigeminal nerve and the release of antiinflammatory neuropeptides.

Indications: treatment of acute migraine with or without aura in adults.

Mode of application:

Contraindications

hypersensitivity to zolmitriptan. Ischemic heart disease, spasm of the coronary arteries.

Uncontrolled arterial hypertension, history cerebrovascular insufficiency or transient ischemic attack.

Side effects

Spasm of the coronary arteries, increased appetite. Liver dysfunction and thirst.

Rarely: anorexia, constipation.

Drowsiness, parasthesia, myalgia, muscle weakness, fatigue.

Storage

Store at a temperature not exceeding 30C, protected from light and out of the reach of children.

Packaging:

The cardboard box contains 1 blister, 4 tablets and paper instructions.